

DOLPHIN-3
81 posts

@DOLPHIN3Study
Drug Optimisation in LMIC of Pregnant HIV Women and Their INfants: Temporary Switch to CAB/RPV Long-Acting Injections (DolPHIN-3) study







Looking forward to day 2 of #nsmc2025. Great to see so many of the @apt_sepsis #MaternalHealthChampions present @AngellaMargare2 @DavidOkiror1 and others. Do come and talk to @PeaceOkwaro @4bitimo and the team as to how we can improve maternal outcomes through #BehaviouralChange.

The #DOLPHIN3 study Uganda site Principal Investigator Prof. @CatrionaWaitt taking participants through the importance of documentation, underlining how visual storytelling through videography strengthens research communication and knowledge sharing. #AtTheEquatorUG

Jim Read presented updates on the #DOLPHIN3 study website, reminding all study sites and work pages leads that impactful communication starts with shared ownership, and that everyone has a role in generating engaging content. #AtTheEquatorUG @t_hoko





















Insightful presentation by the #DOLPHIN3 study Principal Investigator Dr. Thoko Malaba on protocol amendments for Work Package 2 (Clinical Trial), outlining key updates that strengthen the study’s design, implementation, and participant safety. @t_hoko #AtTheEquatorUG






















